Blockchain Registration Transaction Record

Lisata Therapeutics Prepares for Crucial ASCEND Trial Results in 2024

Lisata Therapeutics CEO discusses pivotal year in 2024, Phase 2b ASCEND trial, regulatory milestones, and potential partnership announcements

Lisata Therapeutics Prepares for Crucial ASCEND Trial Results in 2024

Readers should care about Lisata Therapeutics' upcoming pivotal year as it could potentially lead to provisional approval applications, regulatory milestones, and early data points in the oncology field. The company's partnerships and developments may have a significant impact on the future of cancer treatment.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xb0ec89f495e4f760a0ae8c8f92a3f4578b76657a4e7ca8144ba75282306383e4
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintcalmgYa8-3545f65b62495cdb3af8e676a7b3a242